Highest-materiality recent filing
Synergy CHC receives Nasdaq delisting notice for bid price below $1.00
Nasdaq notice on May 15, 2026: stock bid price below $1.00 for 30 consecutive business days.
Q1 2026 revenue $5.49M vs $8.17M YoY; net loss $2.57M vs net income $0.88M; EPS ($0.23) vs $0.10.
Synergy CHC enters up to $36M equity purchase agreement with Hudson Global Ventures
Equity line of credit allows company to sell up to $36M of common stock over 24 months at 95% of market price.
Synergy CHC amends credit agreement, adds EBITDA covenant, issues 3M-share warrant at $0.00001
Amortization revised: $175k quarterly payments in Q3/Q4 2026, $525k Jan 2027, then $350k quarterly.
Gravity Pharma terminates $2.9M brand license agreement ab initio for Synergy CHC
Gravity Pharma terminated Brand License Agreement ab initio for FOCUSfactor and Flat Tummy Co. products in UAE & Turkey.
Synergy CHC Q3 revenue $8.0M (+12.4%); net income falls to $125K from $784K
Revenue $8.0M (+12.4% YoY); gross margin expanded to 70.9% from 67.2%.
Synergy CHC appoints Scott Woodburn as Head of Strategic Partnerships, Teresa Thompson to board
Director Scott Woodburn resigns from board to become Head of Strategic Partnerships for FOCUSfactor Energy Drink expansion.
Synergy CHC Corp. closes $4.375M public offering of 1.75M shares at $2.50/sh
Gross proceeds of $4.375M from 1,750,000 shares at $2.50/sh; underwriters have 45-day option for 262,500 more shares.
EG America, 6th largest U.S. convenience chain with 1,600+ stores, will carry FOCUSfactor Focus + Energy.
Synergy CHC Q2 net income up 125% to $1.5M; completes $20M debt refinancing
Revenue $8.1M (+1% YoY); gross margin expanded to 76.7% from 69.5% on license revenue.
Synergy CHC secures Core-Mark national authorization and Walmart Canada placement for FOCUSfactor
Core-Mark grants national authorization for FOCUSfactor beverages; products hit shelves Q3 2025 across 50,000+ locations.
Synergy CHC stockholders approve 2024 Plan share increase and preferred stock authorization
Approved amendment to 2024 Plan increasing available shares to 2,252,102 (6.18M for, 27K against).
Synergy CHC satisfies $12.7M debt to Knight; issues pre-funded warrant for 428,570 shares
Debt of $12,713,858 to Knight satisfied via $10M cash, $1,213,858 discount, and $1.5M equity conversion.
Synergy CHC secures $20M credit facility (SOFR+8.5%) due May 2029
Term loan of $15M at closing, plus $2.5M delayed draw and $2.5M uncommitted incremental facility.
Synergy CHC Q1 2025 EPS up 30% YoY to $0.10; revenue down 13% to $8.2M
Net income $876.3K, up 51% YoY; diluted EPS $0.10 vs $0.08; ninth consecutive profitable quarter.
Synergy CHC Q4 revenue down 22% to $10.3M; names Jaime Fickett permanent CFO
Q4 revenue $10.3M (-22% YoY); net income $105.7K vs $2.6M; EPS $0.01 vs $0.34.
Synergy CHC Reports Q3 2024: Revenue $7.1M, Net Income $0.8M, Seventh Consecutive Profitable Quarter
Revenue declined 34% to $7.1 million from $10.8 million due to FOCUSfactor rebranding and retailer de-inventorying.
Synergy CHC CFO Stacy Bieber resigns; Jaime Fickett named interim CFO
Stacy Bieber resigned as CFO effective December 6, 2024.
On March 27, 2025, the Board of Directors appointed Jaime Fickett, the Company’s current Interim Chief Financial Officer, to the position of Chief Financial Officer, effective immediately.
Max materiality 0.75 · Median 0.65 · Most common event other_material